Objective: Nasal Polyp (NP) and Allergic Rhinitis (AR) are frequently seen in common. It has been reported that there is an increase in the risk of atherosclerosis in allergic patients. In our study, we aimed to evaluate Mean Platelet Volume (MPV ) values in patients with NP, which is used as a marker of atherosclerosis.
Introduction
Nasal polyps are benign mucosal disorders extending to lumen by proliferating in nasal cavity as a result of mucosal inflammation. NP are the most common reason of nasal masses with a prevalence of 1-4% and it is more common in male gender (1, 2) . It is a multifactorial disease with unclear etiology. Allergy, chronic infection and mechanic, immunological and biochemical factors are implied in the etiology (2) . Mucosal edema is the primary pathology in the development of polyp. Mucosal edema is an inflammation induced by chemical mediators, cytokines and growth factors released from inflammatory cells and endothelial receptors.
Allergic rhinitis generally is associated with clinical presentation in patients with NP. In a study, it was found that incidence of NP was 25% in patients with allergy versus 4% in those without allergy (3) . In that study, it was reported that frequency of allergy varied from 10% to 54% in patients with NP. Nasal Polyp is a multifactorial disorder in which etiology is still unclear; thus, it is intensively investigated. The importance of inflammatory mediators, cytokines, prolonged life span of eosinophils, increased activity of arachidonic acid metabolism and oxidative stress in the etiopathogenesis of NP were reported in several studies (4-6).
Knoflach et al. (7) reported that chronic inflammation and alterations in immune system caused an increase in the risk of atherosclerosis in patients with allergic rhinitis. In another study, it was reported that mediators released from mast cells, which had an important role in the etiopathogenesis of allergic rhinitis, asthma and NP, caused inflammation and fibrosis. As a result, these patients were at high risk for stroke, dilated cardiomyopathy and atherosclerosis (8) .
Mean Platelet Volume (MPV ), which is related to platelet functions and activation, is also used as a marker of atherosclerosis (9) . In many adult studies, MPV is increased in atherosclerotic disorders (10, 11 There are studies reporting incidence of NP as 25% in patients with allergy and the frequency of allergic rhinitis as 10-54% in patients with NP (3). It was reported that rate of allergic rhinitis is about 10-30% in general population and raises up to 45% in children (12) . In our study, allergic rhinitis was seen in 50.6% of NP patients and this result was in agreement with literature.
Biochemical mediators and free radicals that are increased in blood of the patients with NP also affect the development of atherosclerosis, stroke and heart diseases (5, 8) . Although there are studies about the relationship between atherosclerosis and NP or MPV, there is no study focusing directly on the relationship between NP and MPV according to our knowledge (7, 8, 10, 11) .
Most frequent symptom is the nasal congestion in allergic rhinitis which is also one of the most important factors in the development of NP. Other symptoms are itching of nose, sneezing, rhinorrhea and itchy eyes. Nasal congestion causes NP and chronic rhinosinusitis in a long-term by stimulating IgE receptors in mast cells and increasing the release of biochemical mediators (leukotriene, prostaglandin, interleukin-4, tumor necrosis factor-α etc.) (13) (14) (15) (16) . In several studies, it was suggested that increased leukotriene and mast cells played an active role in angiogenesis and caused an increase in the risk of atherosclerosis in patients with allergy (7, 8) .
Since allergy is an important factor in etiopathogenesis of both NP and asthma, it was reported that incidence of asthma was high among patients with NP (17) . In our study, 26.6% of the patients had asthma. Mean number of operations performed due to NP was 1.35±0.83 in patients with NP, whereas it was 2.00±1.25 in NP patients with asthma. Recurrence of NP is more commonly observed in patients with asthma despite surgical and medical therapies (17) . Number of operations was higher in asthmatic patients with NP than non-asthmatic patients with NP in our study. Fairweather et al. (8) reported that mast cells which had a key role in allergic rhinitis and chronic inflammatory diseases such as asthma also had importance in the regulation of inflammation at heart and vessels. In the same study, it was reported that incidence of stroke, atherosclerosis and dilated cardiomyopathy were high in patients with allergic rhinitis and asthma. For this reason, the increased risk of atherosclerosis and cardiac diseases in NP can be expected by the relationship between AR, asthma and NP.
Dagli et al. (5) reported that amount of anti-oxidant was lower in patients with NP while the amount of free radicals, product of oxidation, were significantly higher. Authors suggested that oxidative stress had a major role in the etiopathogenesis of NP and atherosclerosis (18) (19) (20) .
In parallel to our study, Ulasli et al. (21) found that MPV was higher in patients with chronic obstructive pulmonary disease than controls. However, in a study with asthmatic children, Tuncel et al. found no significant difference in MPV values between patients and control groups (22) .
Conclusion
As mentioned above, there may be an increased risk of atherosclerosis due to the chemical and immunological mechanisms in the pathogenesis of NP. However, in our study MPV values were significantly lower in patients with NP than controls.
Thus the results of our study has shown that MPV may not be an appropriate marker in determining the atherosclerosis risk of NP patients. However there are very few studies regarding this subject and further studies are needed.
